Your browser doesn't support javascript.
loading
Safety, Tolerability, Pharmacokinetics and Initial Pharmacodynamics of a Subcommissural Organ-Spondin-Derived Peptide: A Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose First-in-Human Study.
Bourdès, Valérie; Dogterom, Peter; Aleman, André; Parmantier, Pierre; Colas, Damien; Lemarchant, Sighild; Marie, Sébastien; Chou, Thomas; Abd-Elaziz, Khalid; Godfrin, Yann.
Afiliação
  • Bourdès V; Axoltis Pharma, 60 Avenue Rockefeller, 69008, Lyon, France. vbourdes@axoltis.com.
  • Dogterom P; QPS Netherlands B.V., Groningen, The Netherlands.
  • Aleman A; Department of Biomedical Sciences of Cells and Systems, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Parmantier P; Athena Bio Consulting, Lyon, France.
  • Colas D; Athena Bio Consulting, Lyon, France.
  • Lemarchant S; Axoltis Pharma, 60 Avenue Rockefeller, 69008, Lyon, France.
  • Marie S; Axoltis Pharma, 60 Avenue Rockefeller, 69008, Lyon, France.
  • Chou T; QPS LLC, Newark, DE, USA.
  • Abd-Elaziz K; QPS Netherlands B.V., Groningen, The Netherlands.
  • Godfrin Y; Axoltis Pharma, 60 Avenue Rockefeller, 69008, Lyon, France.
Neurol Ther ; 11(3): 1353-1374, 2022 Sep.
Article em En | MEDLINE | ID: mdl-35779189
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Neurol Ther Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Neurol Ther Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França